INTENSITY THERAPEUTICS, INC.

Insiders Intensity Therapeutics, Inc.

Equities

INTS

US45828J1034

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
0.4083 ^USD	-2.34%		-5.94%	-0.46%

Jan. 13	Intensity Therapeutics highlights 2025 milestones and outlines 2026 strategic priorities	RE
Dec. 11	Intensity Therapeutics, Inc. to Present Two Posters At the 2025 San Antonio Breast Cancer Symposium	CI

Insiders

24-05-15	Intensity Therapeutics, Inc. Appoints Thomas Dubin to the Board of Directors	CI
24-04-19	Intensity Therapeutics, Inc. Announces Resignation of Daniel Donovan from Audit Committee of the Board of Directors	CI
23-12-12	Intensity Therapeutics Names Joseph Talamo as Finance Chief	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

Optimize my profits